CRISPR/Cas9-Based Genome Editing: Understanding Differences in DNA Repair Pathways, Profiles, and Outcomes
Samuel N. Effah, Shirley C. Barrera, Nahia Urturi Ortiz, Will Dampier, Michael R. Nonnemacher, Brian Wigdahl · 2026
Read CRISPR/Cas9-Based Genome Editing: Understanding Differences in DNA Repair Pathways, Profiles, and Outcomes by Samuel N. Effah, Shirley C. Barrera, Nahia Urturi Ortiz, Will Dampier, Michael R. Nonnemacher, Brian Wigdahl (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13361962.txt.
Description
Samuel N Effah and co-authors review how cells repair the cuts made by CRISPR gene editing in a 2026 paper. CRISPR/Cas9 can now treat disease: the first approved therapy, for sickle cell anemia, already exists. More are in testing for HIV, inherited cholesterol disease, and cancer. Each therapy's success rests on where the editor is delivered, how cleanly it cuts, and how the cell then repairs the break.
Different repair paths leave different fingerprints at the cut site. Some heal the break neatly; others insert or delete letters, changing the gene. The review covers what steers cells toward each path and how outcomes can be predicted. It also surveys the analysis tools that read repair patterns. Mastering repair is key to making gene editing safer and more precise.
Catalog record
| CREATOR | Samuel N. Effah, Shirley C. Barrera, Nahia Urturi Ortiz, Will Dampier, Michael R. Nonnemacher, Brian Wigdahl |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92155 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |